A Study of Zanidatamab in Combination With Chemotherapy in People With Breast Cancer

Full Title

A Phase 2, Randomized, Multicenter, Open-Label Neoadjuvant Study Evaluating Zanidatamab in Combination with Chemotherapy in Participants with HER2-Positive Breast Cancer

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Joshua Drago’s office at 646-888-6971.

Protocol
26-177
Phase
Phase II (phase 2)
Investigator
Joshua Z. Drago
Co-Investigators
Shanu Modi
Diseases
Breast Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07102381
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description